Oxford Vaccine Group
Nigel Farage Trump
Society
Oxford/AstraZeneca COVID shot less effective against South African variant
British drugmaker AstraZeneca AZN.L said on Saturday its vaccine developed with the University of Oxford appeared to offer only limited protection against mild disease caused by the South African variant of COVID-19.
Domestic COVID vaccine human trials underway
IN-DEPTH
Domestic COVID vaccine human trials underway
 jeremy corbyn
Society
Oxford COVID-19 vaccine may be available this year
MORE STORIES
Society4 years ago
UK signs deals for another 90m doses of COVID-19 vaccine
The UK has secured an agreement for 30m doses of a drug being developed by BioNTech and the German firm Pfizer.
UK signs deals for another 90m doses of COVID-19 vaccine
Society4 years ago
British coronavirus vaccine: Human trials to include 10,000
Oxford University and AstraZeneca are recruiting around 10,000 adults and children in Britain for trials of an experimental coronavirus vaccine, a day after receiving U.S. backing worth up to $1.2 billion.
British coronavirus vaccine: Human trials to include 10,000
Society4 years ago
First human vaccine trial results could come out next month
A member of the government’s coronavirus taskforce says the Results from the UK’s first human trial of a vaccine could be available by the middle of June.
First human vaccine trial results could come out next month
    latestnews
    TOP NEWS
    1
    Society
    UK signs deals for another 90m doses of COVID-19 vaccine
    2
    Society
    British coronavirus vaccine: Human trials to include 10,000
    3
    Society
    First human vaccine trial results could come out next month
    Press TV News Roku